Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome
Recruiting now
Conditions studied: H Syndrome
In brief
H syndrome is a rare genetic disorder predisposing to histiocytosis. Our knowledge of the clinical spectrum of these patients is based on case reports and small patient series. Patients with H syndrome have been treated with a range of immunomodulatory and chemotherapeutic agents, with limited success. We aim to comprehensively assess the clinical manifestations and patterns of treatment response in a multinational cohort of patients with H syndrome.
Key facts
- Study ID
- NCT06742073
- Run by
- Rabin Medical Center
- People needed
- 120
- Starts
- 2024-11-01
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2024-12-19
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Schneider Children's Medical Center — Petah Tikva, Israel (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.